-
D. Boral Capital Reaffirms Buy Rating for Context Therapeutics (NASDAQ:CNTX)
ソース: Buzz FX / 15 1 2025 07:41:15 America/New_York
D. Boral Capital Reaffirms Buy Rating for Context Therapeutics (NASDAQ:CNTX) Written by MarketBeat January 15, 2025 Share Link copied to clipboard. Context Therapeutics ( NASDAQ:CNTX - Get Free Report ) 's stock had its "buy" rating reaffir
Read more...